Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Повний опис

Бібліографічні деталі
Автори:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Формат:	Journal article
Мова:	English
Опубліковано:	Wiley Open Access 2024

Схожі ресурси

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
за авторством: Pan Fu, та інші
Опубліковано: (2022-01-01)

Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
за авторством: Matthew Velazquez, та інші
Опубліковано: (2021-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
за авторством: Oulhaj, A, та інші
Опубліковано: (2016)

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
за авторством: Helia Givian, та інші
Опубліковано: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
за авторством: Jorge Garcia Condado, та інші
Опубліковано: (2023-10-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
за авторством: de Jager, C, та інші
Опубліковано: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
за авторством: De Jager, C, та інші
Опубліковано: (2012)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
за авторством: Luise Christine Löwe, та інші
Опубліковано: (2016-01-01)

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
за авторством: Matteo De Marco, та інші
Опубліковано: (2023-05-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
за авторством: Xiwu Wang, та інші
Опубліковано: (2023-03-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
за авторством: Giulia Arenare, та інші
Опубліковано: (2023-08-01)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
за авторством: Michael J. Pearson, та інші
Опубліковано: (2024-07-01)

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.
за авторством: Christian Gaser, та інші
Опубліковано: (2013-01-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
за авторством: Ali Azargoonjahromi, та інші
Опубліковано: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
за авторством: Asma Hallab, та інші
Опубліковано: (2024-09-01)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
за авторством: Ze Wang, та інші
Опубліковано: (2020-11-01)

Lower functional hippocampal redundancy in mild cognitive impairment
за авторством: Stephanie Langella, та інші
Опубліковано: (2021-01-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
за авторством: Anna Rubinski, та інші
Опубліковано: (2020-10-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
за авторством: Jones, S, та інші
Опубліковано: (2017)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
за авторством: Yi Chen, та інші
Опубліковано: (2021-12-01)

Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.
за авторством: Zhijun Yao, та інші
Опубліковано: (2010-11-01)

Information Flow Pattern in Early Mild Cognitive Impairment Patients
за авторством: Haijuan He, та інші
Опубліковано: (2021-11-01)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
за авторством: Chen Xue, та інші
Опубліковано: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
за авторством: Chao Wang, та інші
Опубліковано: (2024-06-01)

A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.
за авторством: Zhijun Yao, та інші
Опубліковано: (2012-01-01)

The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment
за авторством: Xiwu Wang, та інші
Опубліковано: (2019-02-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
за авторством: Lanlan Li, та інші
Опубліковано: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
за авторством: Gerasimos Grammenos, та інші
Опубліковано: (2024-04-01)

Association of CSF GAP-43 and <i>APOE</i> ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
за авторством: Yueli Zhu, та інші
Опубліковано: (2022-12-01)

Directed network motifs in Alzheimer's disease and mild cognitive impairment.
за авторством: Eric J Friedman, та інші
Опубліковано: (2015-01-01)

The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
за авторством: Silke White, та інші
Опубліковано: (2023-07-01)

Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment
за авторством: Yixue Feng, та інші
Опубліковано: (2022-09-01)

Brain network construction and analysis for patients with mild cognitive impairment and Alzheimer's disease based on a highly‐available nodes approach
за авторством: Xiaopan Zhang, та інші
Опубліковано: (2021-03-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
за авторством: Xiaoming Zheng, та інші
Опубліковано: (2024-10-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
за авторством: Annie M. Racine, та інші
Опубліковано: (2018-01-01)

Homocysteine, B vitamins, and cognitive impairment
за авторством: Smith, A, та інші
Опубліковано: (2016)

Homocysteine, B vitamins, and cardiovascular disease
за авторством: Refsum, H, та інші
Опубліковано: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
за авторством: Refsum, H, та інші
Опубліковано: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
за авторством: Smith, A, та інші
Опубліковано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
за авторством: Smith, A, та інші
Опубліковано: (2010)